Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGES | O14684 | 6/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | ALPL | P05186 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31582268 | 0.81 | PTGES (0.63) | PTGESALDH1A1LMNANPSR1HPGD | |
| SCHEMBL31582548 | 0.80 | NPSR1 (0.57) | PTGESALDH1A1LMNANPSR1HPGD | |
| SCHEMBL25940206 | 0.80 | ALDH1A1 (0.62) | PTGESALDH1A1LMNANPSR1HPGD | |
| SCHEMBL21527261 | 0.79 | NPSR1 (0.66) | PTGESALDH1A1LMNANPSR1HPGD | |
| SCHEMBL26969218 | 0.79 | PTGES (0.76) | PTGESALDH1A1LMNAHPGDRECQL | |
| SCHEMBL31582586 | 0.78 | ALDH1A1 (0.62) | PTGESALDH1A1LMNANPSR1HPGD | |
| SCHEMBL31582564 | 0.77 | PTGES (0.62) | PTGESALDH1A1LMNANPSR1HPGD | |
| SCHEMBL17153778 | 0.76 | NPSR1 (0.71) | PTGESALDH1A1LMNANPSR1HPGD | |
| SCHEMBL12316869 | 0.75 | NPSR1 (0.60) | PTGESALDH1A1LMNANPSR1HPGD | |
| SCHEMBL31582549 | 0.74 | HPGD (0.71) | PTGESALDH1A1LMNAHPGDRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250163006-A1 | New Coolants, and Preparations Containing Same | SYMRISE AG (DE) | 2025-05-22 | — | — | US | claimed |
| WO-2025132323-A1 | COMPOSITIONS COMPRISING A SUNSCREEN ACTIVE AGENT | DSM-FIRMENICH AG (CH) | 2025-06-26 | — | — | WO | disclosed |
| US-20250163006-A1 | New Coolants, and Preparations Containing Same | SYMRISE AG (DE) | 2025-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250163006-A1 | New Coolants, and Preparations Containing Same | TTR, TAS2R5, TAS2R50 | PTGES 1936/4885ALDH1A1 811/4885LMNA 3005/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.